Document Detail


3T deep gray matter T2 hypointensity correlates with disability over time in stable relapsing-remitting multiple sclerosis: a 3-year pilot study.
MedLine Citation:
PMID:  20708201     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Abnormally decreased deep gray matter (GM) signal intensity on T2-weighted MRI (T2 hypointensity) is associated with brain atrophy and disability progression in patients with multiple sclerosis (MS) and is believed to represent excessive iron deposition. We investigated the time course of deep GM T2 hypointensity and its relationship with disability at 3T in 8 stable relapsing-remitting (RR) MS patients treated with minocycline over 3years. MRI and disability measurements were compared at baseline, 6, 12, 24, and 36months. Grand mean deep GM T2 hypointensity was negatively correlated with EDSS over time (r=-0.94, P=0.02). This correlation was strongest in the head of caudate (r=-0.95, P=0.01) and putamen (r=-0.89, P=0.04). Additionally, baseline grand mean deep GM T2 hypointensity appears to predict third year EDSS (r=-0.72, P=0.04). These results suggest that iron associated deep GM injury correlates with patient disability in stable RRMS. Measurements of deep GM T2 hypointensity at high field MRI may prove to be useful in monitoring individuals with MS. Further studies are required to confirm these results in a large sample and to determine if T2 hypointensity changes in clinically active MS patients.
Authors:
Y Zhang; L M Metz; V W Yong; J R Mitchell
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-08-12
Journal Detail:
Title:  Journal of the neurological sciences     Volume:  297     ISSN:  1878-5883     ISO Abbreviation:  J. Neurol. Sci.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-13     Completed Date:  2010-12-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375403     Medline TA:  J Neurol Sci     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  76-81     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier B.V. All rights reserved.
Affiliation:
Department of Clinical Neurosciences, University of Calgary, Canada. yunyzhan@ucalgary.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Analysis of Variance
Anti-Bacterial Agents / therapeutic use
Atrophy / pathology
Brain / pathology*
Disability Evaluation
Disabled Persons*
Female
Humans
Longitudinal Studies
Magnetic Resonance Imaging / methods
Male
Middle Aged
Minocycline / therapeutic use
Multiple Sclerosis, Relapsing-Remitting / complications*,  drug therapy,  pathology*
Nerve Fibers, Unmyelinated / pathology*
Pilot Projects
Severity of Illness Index
Statistics as Topic
Time Factors
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 10118-90-8/Minocycline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The Prominent Expression of Plasma Matrix Metalloproteinase-8 in Acute Thoracic Aortic Dissection.
Next Document:  Weather regimes and orographic circulation around New Caledonia.